{"id":533265,"date":"2021-09-01T08:04:22","date_gmt":"2021-09-01T12:04:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/"},"modified":"2021-09-01T08:04:22","modified_gmt":"2021-09-01T12:04:22","slug":"intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/","title":{"rendered":"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK, Sept.  01, 2021  (GLOBE NEWSWIRE) &#8212; Intercept Pharmaceuticals, Inc.\u00a0(Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that\u00a0Jerry Durso, President and Chief Executive Officer of Intercept, M. Michelle Berrey, M.D., M.P.H., President of Research &amp; Development and Chief Medical Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will present at the virtual Baird 2021 Global Healthcare Conference on\u00a0Tuesday, September 14, 2021\u00a0at\u00a010:15 a.m. ET.<\/p>\n<p>A live webcast of the event will be available on the investor page of Intercept\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TleC48rIAtaLvz-xeMGt1cHf6VEbh5xrx9Z9j9DHc4xtt5lLUPggOyyWTOrLrQyYLJJ97k2yJTD1BquDn2xqxgFBuIEgfE13FtAZY_oB_S4=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/ir.interceptpharma.com<\/a>. An audio archive of the webcast will also be available on Intercept\u2019s website for approximately two weeks.<\/p>\n<p>\n        <strong><br \/>\n          <em>About Intercept<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in\u00a0New York, Intercept has operations in\u00a0the United States,\u00a0Europe\u00a0and\u00a0Canada. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YYH1kw2jDaMGX8MSSxs2iiUo_jUaQsN8t0nReThqzjBheESr4UGnwafpijKQ2NDn48KEJufCV5jkWqQIEjkFLGw9GfUqFDN_CVABJDrdpZE=\" rel=\"nofollow noopener\" target=\"_blank\">www.interceptpharma.com<\/a>\u00a0or connect with the company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0Xh8v2gpGVZ0Sk2fFz9U_Wn07aWr8Q_7Se-UK0Y8Iy5a4Ik6kI_st5ITZtPOAiHmHPdDQi9QIbpp96-lg9vigA==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1wpu6NtWU7AYUJQp2nGOrIBsGREjqGnozGCwrJg3kxW_TIdTOFmCz5X3H9V4heEAFqmPn3ypRuMeJwoevsReSIBUePf3tMZZYYDL4bmxT5S8yK9GhH5sYulccSU9iGc7qAFHA2cv2Yu1HK_0rZg8Jw==\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>CONTACT<\/p>\n<p>For more information about Intercept, please contact:<\/p>\n<p>Investor inquiries:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qQeMVYC5P1pE0jGap0CJcbgaBjc6IogpXRQIy-aQK-G0NFD-vffI72-r1IyYPX9TnDL424XjY1gpZDEPoZvfzrPLyf6vw1H_fUIp742a_9Dg2uzwwCSoE9DfJtOYTIvq\" rel=\"nofollow noopener\" target=\"_blank\">investors@interceptpharma.com<\/a>\u00a0<\/p>\n<p>Media inquiries:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qJzNuVMHYs4biSt48nmAFcnO7xs9N4lfBL7oFJe5V32xuW76n7Ft0LJKsoMDjrb87LLQrXmORs3o58iu-v9EyPlFmhJTnwMXI3a771J3AqI=\" rel=\"nofollow noopener\" target=\"_blank\">media@interceptpharma.com<\/a>\u00a0<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NGU0MzNhMDktNGUzOS00ZDUxLTllZTAtMGU0ZTExODZjNjVlLTEwMTg0MTE=\/tiny\/Intercept-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Sept. 01, 2021 (GLOBE NEWSWIRE) &#8212; Intercept Pharmaceuticals, Inc.\u00a0(Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that\u00a0Jerry Durso, President and Chief Executive Officer of Intercept, M. Michelle Berrey, M.D., M.P.H., President of Research &amp; Development and Chief Medical Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will present at the virtual Baird 2021 Global Healthcare Conference on\u00a0Tuesday, September 14, 2021\u00a0at\u00a010:15 a.m. ET. A live webcast of the event will be available on the investor page of Intercept\u2019s website at\u00a0http:\/\/ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept\u2019s website for approximately two weeks. About Intercept Intercept is a biopharmaceutical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533265","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Sept. 01, 2021 (GLOBE NEWSWIRE) &#8212; Intercept Pharmaceuticals, Inc.\u00a0(Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that\u00a0Jerry Durso, President and Chief Executive Officer of Intercept, M. Michelle Berrey, M.D., M.P.H., President of Research &amp; Development and Chief Medical Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will present at the virtual Baird 2021 Global Healthcare Conference on\u00a0Tuesday, September 14, 2021\u00a0at\u00a010:15 a.m. ET. A live webcast of the event will be available on the investor page of Intercept\u2019s website at\u00a0http:\/\/ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept\u2019s website for approximately two weeks. About Intercept Intercept is a biopharmaceutical &hellip; Continue reading &quot;Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-01T12:04:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference\",\"datePublished\":\"2021-09-01T12:04:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/\"},\"wordCount\":215,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/\",\"name\":\"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=\",\"datePublished\":\"2021-09-01T12:04:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference - Market Newsdesk","og_description":"NEW YORK, Sept. 01, 2021 (GLOBE NEWSWIRE) &#8212; Intercept Pharmaceuticals, Inc.\u00a0(Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that\u00a0Jerry Durso, President and Chief Executive Officer of Intercept, M. Michelle Berrey, M.D., M.P.H., President of Research &amp; Development and Chief Medical Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will present at the virtual Baird 2021 Global Healthcare Conference on\u00a0Tuesday, September 14, 2021\u00a0at\u00a010:15 a.m. ET. A live webcast of the event will be available on the investor page of Intercept\u2019s website at\u00a0http:\/\/ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept\u2019s website for approximately two weeks. About Intercept Intercept is a biopharmaceutical &hellip; Continue reading \"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-01T12:04:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference","datePublished":"2021-09-01T12:04:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/"},"wordCount":215,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/","name":"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=","datePublished":"2021-09-01T12:04:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODA3NiM0MzgzMTg2IzIwMDY4Mzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/intercept-to-present-at-the-virtual-baird-2021-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533265"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533265\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}